Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the U.K. National Health Service and public finances.
In a letter to Pfizer chief executive officer Albert Bourla, the lawmakers noted the company plans to raise the price of its shot to $110 to $130 a dose in the U.S. and they asked him to confirm during an upcoming call with Wall Street analysts and investors that Pfizer will not take the same step in the U.K.
“The U.K. has already been paying the highest known prices for Pfizer’s vaccines, with your company reportedly having already increased the price per dose from (approximately $22 to $27). With Pfizer’s vaccine estimated to cost ($6.15) to produce, even the original price represented a 340% markup,” wrote four lawmakers from the U.K. Parliament.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect